INM

InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. (INM) has 1 SEC Form 4 filing (18 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 11, 2026.

The most active filer is 10% Owner Vivo Opportunity, LLC with 9 filings. Insiders have net bought $392K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Eric A. Adams Chem.
  • Employees:13
  • HQ:Vancouver, BC, CA
  • IPO:2014-05-05

Insider Buying

$392K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$5.0M

latest known value

Source
Purchase$88KJun 11SEC ↗
Purchase$57KJun 11SEC ↗
Purchase$28KJun 11SEC ↗
Purchase$25KJun 11SEC ↗
Purchase$35KJun 11SEC ↗
Purchase$12KJun 11SEC ↗
Purchase$11KJun 11SEC ↗
Purchase$86KJun 11SEC ↗
Purchase$49KJun 11SEC ↗